Fluence Corporation


AU$294.2m market cap

AU$0.48 last close

Fluence is a global supplier of water and wastewater treatment solutions. Its decentralised products provide municipal customers with ‘plug and play’ solutions that are both quicker to deploy and substantially cheaper than traditional alternatives.

Investment summary

In October Fluence raised A$36m (US$25m) through a placement of 81.8m shares at A$0.44. The raise should cover a near-term drain in working capital resulting from the combination of capacity expansion plus a ramp up of Ivory Coast costs. Given the size of these deals, once delivery is underway the company should be sustainably profitable and largely cash generative. A Q3 trading statement is due at the end of the month.

Y/E Dec
Revenue (US$m)
PBT (US$m)
EPS (fd) (c)
P/E (x)
P/CF (x)
2017A 33.2 (23.6) (21.7) (7.0) N/A N/A
2018A 101.1 (8.5) (10.5) (2.5) N/A N/A
2019E 90.0 (21.8) (24.0) (4.4) N/A N/A
2020E 175.9 1.9 (0.4) (0.1) N/A N/A
Industry outlook

Fluence’s ‘plug and play’ solutions can cost-effectively boost the performance of existing centralised treatment plants and address unserved, greenfield rural populations. Aspiral and SUBRE are based on a proprietary technology (MABR) that offers both superior treatment and lower energy costs. We see rising government spending on rural wastewater treatment in China as a particularly large opportunity.

Last updated on 21/11/2019
Share price graph
Balance sheet
Forecast net cash (US$m) 23.5
Forecast gearing ratio (%) N/A
Price performance
Actual 5.6 9.2 23.4
Relative* 5.2 5.9 4.2
52-week high/low A$0.6/A$0.3
*% relative to local index
Key management
Henry Charrabe CEO
Richard Irving Executive Chairman